483
Weiner, Gilbert R.FDA 483 - Weiner, Gilbert R. - November 25, 2013
Record Details
The FDA inspection of Gilbert R. Weiner, a clinical investigator in Aventura, FL, revealed significant deviations in the conduct of a clinical trial. Key findings included a failure to adhere to the investigational plan, inadequate maintenance of case histories, and issues with the informed consent process. These observations highlight serious deficiencies in protocol execution and documentation practices during clinical research.
Open in Dashboard
ID · 9e24920c-65c3-44b0-b674-0a3b1ab43ed6